Clinical Trial Update: A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008) [Phase 3]

View source ↗

Summary

Phase 3 study MK-1026-008/BELLWAVE-008 is evaluating nemtabrutinib against chemoimmunotherapy in previously untreated chronic lymphocytic leukemia/small lymphoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Nemtabrutinib (nemtabrutinib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING